Discontinued — last reported Q3 '25
West Pharmaceutical Services Payments for finance leases remained flat by 0.0% to $300.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 50.0%, from $200.00K to $300.00K. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests higher reliance on leased assets or expansion of the asset base, while a decrease indicates debt reduction or fewer new lease agreements.
Represents the cash outflows associated with the principal portion of finance lease obligations. These payments reflect...
Standard across capital-intensive industries; peers in semiconductor equipment often report this as part of financing cash flows.
payments_for_finance_leases| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $100.00K | $100.00K | $22.90M | $300.00K | $100.00K | $200.00K | $300.00K | $300.00K | $300.00K | $300.00K |
| QoQ Change | — | — | — | — | — | — | — | — | +0.0% | >999% | -98.7% | -66.7% | +100.0% | +50.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | +0.0% | +100.0% | -98.7% | +0.0% | +200.0% | +50.0% |